器官移植市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、按应用、移植类型、最终用户、地区和竞争细分

2022年，全球器官移植市场估值达到145.6亿美元，预计在预测期内将大幅成长，预计复合年增长率（CAGR）为8.93%，到2028年预计将达到241.7亿美元。器官移植市场主要围绕器官移植的复杂过程。器官移植是一种医疗程序，从一个人身上提取器官并植入另一个人体内，以解决器官衰竭、弥补缺口或替换受损或缺失的器官。此手术通常用于治疗肺、肾、肝等关键器官的器官衰竭。最常见的器官移植候选人是脑死但拥有可以挽救他人生命的健康器官的人。在开始这项复杂的程序之前，获得患者或家人的同意至关重要，因为未经同意摘取器官被认为是非法的且在道德上是错误的。

主要市场驱动因素

市场概况
预测期	2024-2028
2022 年市场规模	145.6亿美元
2028 年市场规模	241.7亿美元
2023-2028 年复合年增长率	8.93%
成长最快的细分市场	免疫抑制剂药物
最大的市场	北美洲

1. 不断升级的器官衰竭和器官捐赠程序：

过去十年，全球器官移植的需求稳定成长。这可归因于重要器官衰竭发生率的增加、移植成功率的提高以及移植后结果的改善。由于饮酒、药物滥用和不健康饮食等因素导致器官衰竭的发生率上升，导致影响肺部、肾臟和肝臟等重要器官的慢性疾病。器官移植已成为病患的救命手段，因而带动了移植市场的扩张。此外，移植方法的技术进步正在促进市场整体收入的成长。

2. 移植器官需求激增：

全球对移植器官的需求上升可归因于急性疾病的增加导致器官衰竭的发生率较高。例如，主要由糖尿病和高血压等疾病引起的末期肾病变需要肾臟移植或透析作为维持患者生命的唯一治疗选择。根据美国卫生与公众服务部的数据，2019 年美国约有 121,678 名患者等待器官移植。对解决器官衰竭的先进移植产品的巨大需求正在推动市场成长。

3. 组织库数量不断增加：

组织移植的需求促进了组织库的发展，组织库是在低温条件下储存生物医学组织的实体。例如，烧伤人数的增加导致对专门用于捐赠皮肤的检索和无菌储存的组织库的巨大需求。技术进步，包括冷冻保存系统和电脑化支援系统，显着提高了组织保存的效率。这些进步使器官的储存和检索更加方便，从而推动了市场的成长。

4. 器官移植方法的技术进步：

3D生物列印领域的技术突破在推动器官移植的采用方面发挥关键作用。 PCR 技术的不断发展，包括系统设计和先进检测方法的改进，大大提高了组织分型的精确度和有效性。约翰霍普金斯大学医学院开发的突破性技术称为脱敏技术，透过允许使用任何捐赠者的器官，彻底改变了肾臟移植。此外，利用目标温度管理的低温治疗已成为器官移植的关键因素，可保护心臟骤停、窒息和中风患者的神经功能。这些先进技术的引入促进了全球移植市场的成长，导致全球器官移植手术数量的增加。

主要市场挑战

移植排斥：

移植排斥是一个复杂的过程，受体的免疫系统对移植的器官或组织发动攻击，将其识别为外来物。三种常见类型的排斥反应包括超急性排斥反应、急性排斥反应和慢性排斥反应。儘管进行了仔细的捐赠者配对、组织分型和使用免疫抑制药物，但移植排斥的情况仍然发生，导致器官衰竭。不遵守免疫抑制药物治疗仍是导致排斥反应的重要因素。移植排斥可能引起的併发症包括某些类型的癌症、感染、移植组织或器官的功能受损以及因药物剂量不正确而导致的不良反应。根据器官采购和移植网络的数据，大约 4% 的死亡捐赠者肾臟移植在一年内失败，而活体捐赠者肾臟移植受者在移植后五年内面临 14% 的失败率。因此，这些因素对市场的成长构成了挑战。

器官捐赠者短缺：

根据活体肾臟捐赠者网路的数据，2017年全球肾臟移植受者人数超过9万人，预计这数字在不久的将来还会上升。传统上，器官是从经历过脑损伤或中风的已故患者身上获得的。然而，吸烟、酗酒和滥用药物的盛行导致适合器官捐赠的健康人群减少。因此，由于可供移植的合适器官仍然有限，等待移植的患者数量不断增加。此外，对器官捐赠缺乏认识已成为阻碍市场成长的重要因素。此外，伦理和文化的考量对移植市场构成了巨大的挑战。发展中国家和欠发达国家往往对器官捐赠缺乏认识，导致潜在的器官捐赠者犹豫不决。文化和社会耻辱以及宗教和习俗信仰常常阻碍家庭之间的器官捐赠。这些因素共同阻碍了市场的成长前景。

主要市场趋势

科技与发展的进步：

技术和发展的进步透过解决该领域目前面临的一些挑战和限制，具有显着增加未来器官移植需求的巨大潜力。医学领域的技术进步和发展促进了心臟、肾臟、肝臟、肺部和各种其他器官等重要器官的移植。关键技术成就包括血管吻合技术的发展、透过化学免疫抑制剂有效管理免疫反应以及保存液的配製。

这些进步可以提高器官可用性、提高移植成功率并扩大移植的可能性。技术有潜力增强器官保存和运输方法，使器官在移植前保持更长的存活时间。这可以实现更有效的器官分配、减少浪费以及更广泛地获得活器官。生物列印和组织工程的进步使得在实验室中创建生物工程器官和组织成为可能。这项技术有潜力透过按需生产器官来解决器官短缺问题，减少对捐赠器官的依赖。免疫抑制药物的发展可以带来更有针对性和更有效的治疗，从而最大限度地降低器官排斥的风险。改进的免疫抑制方案可以提高移植手术的成功率并减少对高药物剂量的需求。异种移植（将动物的器官移植到人类身上）的研究有可能克服人类捐赠者器官的短缺。基因编辑和免疫调节的进步使异种移植变得更加可行和安全。

再生医学的进展：

再生疗法和组织工程有可能透过提供传统供体器官的替代品来彻底改变器官移植。生物工程组织、类器官和实验室培养器官的开发可以增加可移植组织的可用性。科学家正在实验室中利用细胞、支架和生长因子的组合来创造功能性组织。这些生物工程组织可用于修復受损器官、恢復功能或在等待合适的捐赠器官时提供临时支撑。类器官是实验室中用干细胞培育的器官的微型简化版。它们密切模仿实际器官的结构和功能，这使得它们对于研究疾病、测试药物反应以及未来可能用作可移植组织具有重要价值。生物工程组织和器官有可能利用患者自身的细胞来创建，从而降低排斥风险和对免疫抑制药物的需求。

细分市场洞察

应用见解：

全球器官移植市场依应用分为器官移植和组织移植。 2022年，器官移植领域的收入份额最高。这可以归因于全球器官移植需求的不断增长，而酗酒和不健康生活方式导致器官衰竭的病例增加。此外，主要参与者和医疗保健专业人员的持续技术进步提高了成功率和移植后预后，从而推动了该领域的收入成长。另一方面，组织移植领域预计在预测期内将呈现稳定的成长速度。对角膜、骨骼、皮肤、神经、肌腱、静脉和心臟瓣膜移植的需求很大，特别是对于遭受烧伤和事故影响的个体。

最终使用者见解：

根据最终用户，全球移植市场分为医院、移植中心和其他设施。医院业务在 2021 年收入中所占份额最大，主要是由于医院进行的医疗程序和手术数量不断增加。大多数医院都可以方便地存取明确的器官资料库，这有助于验证器官供应并能够及时进行医疗干预。这项因素有助于医院部门的收入成长。移植中心部门预计在预测期内将呈现稳定的收入成长率。这可以归因于对先进医疗中心的需求不断增长，以满足日益增长的移植手术需求。移植中心特别适合老年人，因为它们提供个人化护理并最大限度地减少频繁去医院的需要。此外，在移植中心接受治疗有助于降低医院获得性感染的风险。

区域见解：

根据区域分析，2022年北美移植市场占收入份额最大。该地区市场的成长得益于创新移植产品的不断开发、发达的医疗保健系统以及个人健康支出的增加人口。此外，各种大型生物技术和医疗器材公司的强劲存在预计将进一步推动北美的收入成长。此外，加拿大和美国政府的支持性政策也促进了该地区市场的成长。预计亚太地区市场在预测期内将经历更快的收入成长率。慢性病盛行率的不断上升以及导致永久性器官损伤的道路事故的增加是推动该地区收入成长的主要因素。此外，该地区国家主要参与者移植技术的不断进步有助于亚太移植市场的收入成长。同时，欧洲市场预计在预测期内将保持稳定的高收入成长率。药物和酒精消费的增加导致器官损伤，加上主要市场参与者的强大存在和熟练医生的可用性，正在推动该地区市场的收入成长。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球器官移植市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产品（组织产品、器官保存产品、移植诊断、免疫抑制药物、其他）
  • 按应用（器官移植、组织移植）
  • 依移植类型（自体移植、同种异体移植、其他）
  • 按最终使用者（医院、移植中心、其他）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美器官移植市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按移植类型
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲器官移植市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按移植类型
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区器官移植市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按移植类型
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲器官移植市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按移植类型
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第10章：中东和非洲器官移植市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按移植类型
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非器官移植
  • 沙乌地阿拉伯器官移植
  • 阿联酋器官移植

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球口腔临床营养市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 服务内容
• 最近的发展
• 主要人员
• SWOT分析
  • Abbvie, Inc.
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic plc
  • Novartis AG
  • Stryker Corporation
  • 21st Century Medicine
  • BiolifeSolutions, Inc.
  • Teva Pharmaceuticals
  • Veloxis Pharmaceutical

第 16 章：策略建议

第 17 章：关于我们与免责声明

The Global Organ Transplant Market reached a valuation of USD 14.56 Billion in 2022 and is expected to experience substantial growth during the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 8.93% and expected to reach USD 24.17 Billion through 2028. The organ transplantation market primarily revolves around the intricate process of transplanting organs. Organ transplantation is a medical procedure where an organ is extracted from one individual and implanted into another to address organ failure, bridge gaps, or replace damaged or missing organs. This procedure is commonly utilized to treat organ failure in critical organs such as the lungs, kidneys, liver, and others. The most common candidates for organ transplantation are individuals with brain death but possessing healthy organs that can potentially save another person's life. Before embarking on this complex procedure, obtaining patient or family consent is crucial, as harvesting organs without consent is considered unlawful and ethically wrong.

The organ transplant market pertains to the healthcare industry sector dedicated to the transplantation of organs and tissues from one individual (donor) to another (recipient) to replace a malfunctioning or damaged organ. Organ transplantation is a multifaceted medical procedure designed to enhance the quality of life and extend the lifespan of individuals with organ failure or specific medical conditions. The market encompasses various aspects related to organ transplantation, including organ procurement, preservation, transplantation surgery, post-operative care, and ongoing management.

Key Market Drivers

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 14.56 Billion
Market Size 2028	USD 24.17 Billion
CAGR 2023-2028	8.93%
Fastest Growing Segment	Immunosuppressant Drugs
Largest Market	North America

1. Escalating Organ Failures and Organ Donation Procedures:

Over the past decade, the demand for organ transplantation has been steadily increasing worldwide. This can be attributed to the heightened prevalence of vital organ failure, improved success rates in transplantation, and better post-transplant outcomes. The incidence of organ failure has also risen due to factors such as alcohol consumption, substance abuse, and unhealthy diets leading to chronic diseases affecting crucial organs such as the lungs, kidneys, and liver. Organ transplantations have become life-saving measures for patients, thus driving the expansion of the transplantation market. Moreover, technological advancements in transplantation methods are contributing to the overall revenue growth of the market.

2. Surge in the Demand for Transplant Organs:

The global upswing in demand for transplant organs can be attributed to the increasing occurrence of acute diseases leading to a higher prevalence of organ failures. For example, end-stage renal disease, primarily caused by conditions like diabetes and high blood pressure, necessitates kidney transplants or dialysis as the sole treatment options to sustain patient life. As per the U.S. Department of Health & Human Services, approximately 121,678 patients were awaiting organ transplants in the U.S. in 2019. This substantial demand for advanced transplantation products to address organ failure is propelling market growth.

3. Growing Number of Tissue Banks:

The need for tissue transplantation has catalyzed the growth of tissue banks, entities that store biomedical tissues under cryogenic conditions. The rise in burn injuries, for instance, has led to a significant demand for tissue banks specialized in the retrieval and aseptic storage of skin for donation. Technological advancements, including cryopreservation systems and computerized support systems, have significantly improved the efficiency of tissue preservation. These advancements are making the storage and retrieval of organs more convenient, thus fueling the market's growth.

4. Technological Advancements in Organ Transplant Methods:

Technological breakthroughs in the realm of 3D bioprinting are playing a pivotal role in driving the adoption of organ transplantation. Continuous developments in PCR techniques, including improvements in system design and advanced assays, have greatly enhanced the precision and effectiveness of tissue typing. The groundbreaking technique known as desensitization, developed by John Hopkins University School of Medicine, has revolutionized kidney transplantation by enabling the use of organs from any donor. Additionally, therapeutic hypothermia, utilizing targeted temperature management, has emerged as a critical factor in organ transplantation, safeguarding neurological functions in patients with cardiac arrest, asphyxia, and stroke. The introduction of these advanced techniques has contributed to the growth of the global transplantation market, leading to an increase in the number of organ transplant procedures worldwide.

Key Market Challenges

Transplant Rejection:

Transplant rejection is a intricate process in which the recipient's immune system launches an attack against the transplanted organ or tissue, recognizing it as foreign. Three common types of rejections include hyper-acute rejection, acute rejection, and chronic rejection. Despite careful donor matching, tissue typing, and the use of immunosuppressive medications, instances of transplant rejection still occur, resulting in organ failure. Non-compliance with immunosuppressive drugs remains a significant contributing factor to rejection. Complications that may arise from transplant rejection include certain types of cancers, infections, impaired function of the transplanted tissue or organ, and adverse effects due to incorrect medication dosages. According to the Organ Procurement and Transplantation Network, approximately 4% of deceased donor kidney transplants experience failure within one year, while living donor kidney transplant recipients face a 14% failure rate at five years post-transplant. Consequently, these factors pose challenges to the growth of the market.

Shortage of Organ Donors:

As per the Living Kidney Donors Network, the global number of kidney transplant recipients exceeded 90,000 in 2017, and this figure is projected to rise in the near future. Traditionally, organs are procured from deceased patients who have experienced brain injury or stroke. However, the prevalence of smoking, alcohol consumption, and drug abuse has led to a decline in the pool of healthy individuals suitable for organ donation. Consequently, there is a growing number of patients on transplant waiting lists, as the availability of suitable organs for transplantation remains limited. Additionally, the lack of awareness surrounding organ donation has emerged as a significant factor impeding market growth. Furthermore, ethical and cultural considerations pose substantial challenges in the transplantation market. Developing and underdeveloped nations often exhibit a lack of awareness regarding organ donation, contributing to hesitancy among potential organ donors. Cultural and social stigmas, as well as religious and customary beliefs, frequently discourage organ donation among families. These factors collectively hinder the market's growth prospects.

Key Market Trends

Advancements in Technology and Development:

Advancements in technology and development hold significant potential to substantially boost the demand for organ transplants in the future by addressing some of the challenges and limitations currently faced by the field. Technological progress and developments in the medical field have facilitated the transplantation of vital organs like the heart, kidney, liver, lungs, and various other organs. Key technical achievements encompass the development of vascular anastomosis techniques, effective management of the immune response through chemical immunosuppressants, and the formulation of preservation solutions.

These advancements can enhance organ availability, improve transplant success rates, and expand the possibilities for transplantation. Technology has the potential to enhance organ preservation and transportation methods, enabling organs to remain viable for longer periods before transplantation. This can lead to more efficient organ allocation, reduced wastage, and broader access to viable organs. Advances in bioprinting and tissue engineering are enabling the creation of bioengineered organs and tissues in the laboratory. This technology has the potential to address organ shortages by producing organs on demand, reducing the dependency on donor organs. Developments in immunosuppressive medications can lead to more targeted and effective treatments that minimize the risk of organ rejection. Improved immunosuppressive protocols can increase the success rate of transplant surgeries and reduce the need for high medication doses. Research into xenotransplantation, the transplantation of organs from animals to humans, holds the potential to overcome the shortage of human donor organs. Advances in genetic editing and immunomodulation are making xenotransplantation more feasible and safer.

Advancements in Regenerative Medicine:

Regenerative therapies and tissue engineering have the potential to revolutionize organ transplantation by providing alternatives to traditional donor organs. The development of bioengineered tissues, organoids, and lab-grown organs could increase the availability of transplantable tissues. Scientists are working on creating functional tissues in the laboratory using a combination of cells, scaffolds, and growth factors. These bioengineered tissues could be used to repair damaged organs, restore function, or provide temporary support while waiting for a suitable donor organ. Organoids are miniature, simplified versions of organs grown in the lab from stem cells. They closely mimic the structure and function of actual organs, making them valuable for studying diseases, testing drug responses, and potentially serving as transplantable tissues in the future. Bioengineered tissues and organs can potentially be created using a patient's own cells, reducing the risk of rejection and the need for immunosuppressive medications.

Segmental Insights

Application Insights:

The global organ transplant market is divided into organ transplantation and tissue transplantation based on application. The organ transplant segment accounted for the highest revenue share in 2022. This can be attributed to the increasing demand for organ transplantation worldwide, driven by a rise in cases of organ failure resulting from heavy alcohol consumption and an unhealthy lifestyle. Moreover, continuous technological advancements by key players and healthcare professionals have improved the success rate and post-transplant prognosis, thereby fueling the revenue growth of this segment. On the other hand, the tissue transplant segment is expected to exhibit a steady growth rate during the forecast period. There is a significant demand for transplants of corneas, bones, skin, nerves, tendons, veins, and heart valves, especially for individuals affected by burns and accidents.

End User Insights:

Based on end-users, the global transplantation market is categorized into hospitals, transplant centers, and other facilities. The hospital segment accounted for the largest share of revenue in 2021, primarily due to the increasing number of medical procedures and operations performed in hospitals. Most hospitals have convenient access to well-defined organ databases, which facilitates the verification of organ supply and enables prompt medical interventions. This factor contributes to the revenue growth of the hospital segment. The transplant centers segment is expected to exhibit a stable revenue growth rate during the forecast period. This can be attributed to the growing demand for advanced healthcare centers to meet the increasing need for transplantation procedures. Transplant centers are particularly suitable for older adults as they provide personalized care and minimize the need for frequent visits to hospitals. Moreover, receiving treatment in transplant centers helps reduce the risk of hospital-acquired infections.

Regional Insights:

Based on regional analysis, the transplantation market in North America accounted for the largest share of revenue in 2022. The market's growth in this region is driven by continuous development of innovative transplantation products, a well-developed healthcare system, and increased personal health expenditure by the population. Additionally, the strong presence of various large-scale biotechnology and medical device companies is expected to further drive revenue growth in North America. Moreover, supportive government policies in Canada and the US contribute to the market's growth in this region. The market in the Asia Pacific region is projected to experience a faster revenue growth rate during the forecast period. The increasing prevalence of chronic diseases and the rise in road accidents leading to permanent organ damage are major factors driving revenue growth in this region. Furthermore, continuous advancements in transplantation technology by major players in countries within this region contribute to the revenue growth of the Asia Pacific transplantation market. Meanwhile, the European market is expected to maintain a steady high revenue growth rate during the forecast period. The increasing consumption of drugs and alcohol resulting in organ damage, combined with the strong presence of major market players and availability of skilled doctors, are driving the revenue growth of the market in the region.

Key Market Players

• Abbvie, Inc.
• Arthrex, Inc.
• Zimmer Biomet
• Medtronic plc
• Novartis AG
• Stryker Corporation
• 21st Century Medicine
• BiolifeSolutions, Inc.
• Teva Pharmaceuticals
• Veloxis Pharmaceutical

Report Scope:

In this report, the Global Organ Transplant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Transplant Market, By Product:

• Tissue Products
• Organ Preservation Products
• Transplant Diagnostics
• Immunosuppressant Drugs
• Others

Organ Transplant Market, By Application:

• Organ Transplantation
• Tissue Transplantation

Organ Transplant Market, By Type of Transplant:

• Autograft
• Allograft
• Others

Organ Transplant Market, By End User:

• Hospitals
• Transplant Centers
• Others

Organ Transplant Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Organ Transplant Market.

Available Customizations:

• Global Organ Transplant market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ Transplant Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Tissue Products, Organ Preservation Products, Transplant Diagnostics, Immunosuppressant Drugs, Others)
  • 5.2.2. By Application (Organ Transplantation, Tissue Transplantation)
  • 5.2.3. By Type of Transplant (Autograft, Allograft, Others)
  • 5.2.4. By End User (Hospitals, Transplant Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2022)
• 5.3. Market Map

6. North America Organ Transplant Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Type of Transplant
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organ Transplant Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Type of Transplant
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Organ Transplant Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Type of Transplant
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Organ Transplant Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Type of Transplant
      • 6.3.3.2.4. By End User

7. Europe Organ Transplant Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Type of Transplant
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organ Transplant Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Type of Transplant
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Organ Transplant Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Type of Transplant
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Organ Transplant Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Type of Transplant
      • 7.3.3.2.4. By End User
  • 7.3.4. France Organ Transplant Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Type of Transplant
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Organ Transplant Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Type of Transplant
      • 7.3.5.2.4. By End User

8. Asia-Pacific Organ Transplant Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Type of Transplant
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Organ Transplant Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Type of Transplant
      • 8.3.1.2.4. By End User
  • 8.3.2. India Organ Transplant Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Type of Transplant
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Organ Transplant Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Type of Transplant
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Organ Transplant Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Type of Transplant
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Organ Transplant Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Type of Transplant
      • 8.3.5.2.4. By End User

9. South America Organ Transplant Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Type of Transplant
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Organ Transplant Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Type of Transplant
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Organ Transplant Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Type of Transplant
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Organ Transplant Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Type of Transplant
      • 9.3.3.2.4. By End User

10. Middle East and Africa Organ Transplant Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Type of Transplant
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Organ Transplant Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Type of Transplant
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Organ Transplant Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Type of Transplant
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Organ Transplant Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Type of Transplant
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Abbvie, Inc.
  • 15.5.2. Arthrex, Inc.
  • 15.5.3. Zimmer Biomet
  • 15.5.4. Medtronic plc
  • 15.5.5. Novartis AG
  • 15.5.6. Stryker Corporation
  • 15.5.7. 21st Century Medicine
  • 15.5.8. BiolifeSolutions, Inc.
  • 15.5.9. Teva Pharmaceuticals
  • 15.5.10. Veloxis Pharmaceutical

16. Strategic Recommendations

17. About Us & Disclaimer